海正药业：欧盟撤销台州工厂GMP不符合声明

Core Viewpoint - The European Union has revoked the GMP non-compliance declaration for Haizheng Pharmaceutical's Taizhou factory, positively impacting the company's product sales in the EU and other markets [1] Summary by Relevant Sections - Regulatory Update - The EU's revocation of the GMP non-compliance declaration for the Taizhou factory occurred on October 17, 2025 [1] - The official EU database no longer shows the GMP non-compliance status for the Taizhou factory, indicating a return to compliance [1] - Market Impact - The lifting of the non-compliance status is expected to have a positive effect on the company's ability to sell products in the EU market and potentially other markets [1]